Dec 3, 2015 · While we like many aspects of the specialty pharmaceutical business model and admire a handful of the companies, it astounds us at how different specialty pharma …

Our goal at Spes is to identify and address the overlooked and unmet medical needs of the healthcare industry through patient-focused, innovative products. We are dedicated to providing solutions to improve the clinical benefits of patients and the experience of …

Mar 15, 2012 · If a biotech is developing an asset likely to attract a big pharma deal and have a significant impact on patients, does the fact that they did not discover it in house make them specialty pharma? What is specialty pharma, anyway?

Specialty pharmacy refers to distribution channels designed to handle specialty drugs — pharmaceutical therapies that are either high cost, [1] [2] [3] high complexity [3] and/or high touch. [2] High touch refers to higher degree of complexity in terms of distribution, administration, or patient management which drives up the cost of the drugs.

BioPharmaSpec is a global Contract Research Organization specializing in the structural and physicochemical analysis of biopharmaceuticals. Would you like advice? Contact us today! Our experienced scientists can help you characterize your biopharmaceutical, identify product impurities, obtain batch-to-batch comparability data and much more!

La pharmacie Torani et Haddad – Traitements d’oncologie vous offre les informations et les conseils sur le cancer et les traitements d’oncologie. Nos professionnels de la santé on l’expertise et les connaissances pour vous accompagner durant vos traitement.

Defined by their complexity, high cost, and targeted approach to treating rare, chronic, or complex diseases, specialty pharmaceuticals continue to revolutionize healthcare by offering life-changing therapies to patients previously left without viable treatment options.

www.spec-pharma.org

This paper examines the characteristics of specialty pharmaceuticals; the growth of new expertise to handle and manage these pharmaceuticals; and the needs these products create for patients, health plans and practitioners.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company's extensive expertise in product development has been...

This report lists the top Specialty Pharmaceuticals companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Specialty Pharmaceuticals industry.

La pharmacie Torani et Haddad vous offre une livraison gratuite, rapide, sécuritaire et discrète partout au Québec. Service d’urgence. Procédures sécuritaires et strictes. Envois réfrigérés lorsque le médicament le requiert. Emballage saisonnier selon la température extérieure pour protéger les médicaments.

We offer specialized treatments for oncology, neurology, rhumatology, dermatology, gastroenterology, rare illnesses, to name a few. Free delivery to anywhere in Québec; protocol guaranteeing ideal temperatures for all drugs. Vaccination center at Torani and Haddad Pharmacy …

Spec-Pharma is a pharmacy that offers medications and treatments to patients and health professionals.

Find company research, competitor information, contact details & financial data for SPEC PHARMA, LLC of Austin, TX. Get the latest business insights from Dun & Bradstreet.

Spec-Pharma is a pharmaceutical company based in Mont-Royal, QC, specializing in the development and production of innovative medications. With a focus on research and quality control, Spec-Pharma aims to address a variety of health needs through its diverse range of pharmaceutical products.

Nov 15, 2014 · Specialty medicines are prescription drugs that require special handling, distribution, and/or administration. Many specialty medicines are biologics that are delivered via an injection or an infusion and are used to treat chronic, complex diseases.

Apr 29, 2011 · Current European-based specialty pharma companies are in transition, awaiting key regulatory decisions, overhauling management or engaged in M&A. Their fates will help answer a critical question: under what circumstances can this class of companies continue to deliver long-term growth as independent entities?